Results

Total Results: 5 records

Showing results for "chronic kidney diseases".
Users also searched for: health literacy

  1. cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
    January 01, 2024 - ESRD, ESRD encounter, dialysis procedure, and dependence on dialysis as exclusions: Chronic kidney disease … The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … further states, “People with chronic kidney disease are at higher risk of side effects from lipid … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … www.acc.org/latest-in-cardiology/articles/2016/05/31/13/00/lipid-management-guidelines-for-adults-with-chronic-kidney-disease
  2. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
    January 01, 2024 - Chronic kidney disease has been associated with an increased risk of CVD.14 However, multiple studies … The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … further states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
  3. cds.ahrq.gov/sites/default/files/cds/artifact/1056/2023_CDS_Connect_IG_Statin_CVD_Patient_Facing.pdf
    January 01, 2023 - Chronic kidney disease has been associated with an increased risk of CVD.13 However, multiple studies … The ACC states, “People with chronic kidney disease are at higher risk of side effects from lipid medications … further states “People with chronic kidney disease are at higher risk of side effects from lipid medications … Lipid Management Guidelines for Adults with Chronic Kidney Disease. … KDIGO Clinical Practice Guideline for Lipid Management in Chronic Kidney Disease.
  4. cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
    January 01, 2003 - N18.2 Chronic kidney disease, stage 2 (mild) 313863 Bisacodyl 5 MG Rectal Suppository … N18.3 Chronic kidney disease, stage 3 (moderate) 314087 Magnesium Hydroxide 240 MG/ML Oral Suspension … N18.4 Chronic kidney disease, stage 4 (severe) 314113 Magnesium Oxide 200 MG Oral Tablet … N18.5 Chronic kidney disease, stage 5 317055 Aluminum Hydroxide 200 MG / Magnesium Hydroxide 200 MG … kidney disease, unspecified 343017 Mineral Oil 1000 MG/ML Oral Solution Hepatic Dysfunction
  5. cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
    January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 04/19/2017 Time 01:00 – 3:00 PM EST AGENDA · Welcome · Brief Overview of Existing CDS Connect Artifacts · Clarify Logic Details for USPTF-related Artifacts · Discuss Best Approach for Transforming eCQM Specifications into CDS Logic · Next Steps an…

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: